Showing results (311-320 of 436) with videos related to
Sort By:
Pageof 44
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 20, 2006
Phase II trial of bexarotene capsules in patients with advanced non-small-cell lung cancer after failure of two or more previous therapiesRamaswamy Govindan, John Crowley, Lee Schwartzberg, et al.Clinical Lung Cancer|October 10, 2006
Long-term survival with concurrent chemoradiation therapy followed by consolidation docetaxel in stage IIIB non-small-cell lung cancer: a phase II Southwest Oncology Group Study (S9504)David R Gandara, Kari Chansky, Kathy S Albain, et al.JAMA Oncology|June 5, 2025
Long-Term Follow-Up of Patients With Multiple Myeloma Treated on Earlier Total Therapy Protocols: A Secondary Analysis of 3 Clinical TrialsSamer Al Hadidi, Obada Ehab Ababneh, Carolina D Schinke, et al.Haematologica|October 2, 2010
Proliferation is a central independent prognostic factor and target for personalized and risk-adapted treatment in multiple myelomaDirk Hose, Thierry Rème, Thomas Hielscher, et al.Blood|May 31, 2007
The syndecan-1 heparan sulfate proteoglycan is a viable target for myeloma therapyYang Yang, Veronica MacLeod, Yuemeng Dai, et al.British Journal of Haematology|November 18, 2003
Survival after relapse following tandem autotransplants in multiple myeloma patients: the University of Arkansas total therapy I experienceAthanasios B-T Fassas, Bart Barlogie, Susan Ward, et al.Blood|February 6, 2014
Jumping translocations of 1q12 in multiple myeloma: a novel mechanism for deletion of 17p in cytogenetically defined high-risk diseaseJeffrey R Sawyer, Erming Tian, Christoph J Heuck, et al.Blood Advances|December 5, 2023
Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-upSamer Al Hadidi, Obada Ehab Ababneh, Carolina D Schinke, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 4, 2007
The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancerRamón Rami-Porta, David Ball, John Crowley, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|August 5, 2009
The IASLC Lung Cancer Staging Project: proposals regarding the relevance of TNM in the pathologic staging of small cell lung cancer in the forthcoming (seventh) edition of the TNM classification for lung cancerEric Vallières, Frances A Shepherd, John Crowley, et al.Pageof 44